Project Details
Short title | TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma |
---|---|
Status | Finished |
Effective start/end date | 15/01/14 → 1/06/21 |
Funding
- BLOODWISE